Invention Grant
- Patent Title: Chemical compounds
-
Application No.: US15873965Application Date: 2018-01-18
-
Publication No.: US10202391B2Publication Date: 2019-02-12
- Inventor: Clifford David Jones , Richard Andrew Ward , Mark Andrew Graham , Steven Swallow , Andrew Hornby Dobson , James Francis McCabe
- Applicant: AstraZeneca AB
- Applicant Address: SE Sodertalje
- Assignee: AstraZeneca AB
- Current Assignee: AstraZeneca AB
- Current Assignee Address: SE Sodertalje
- Agent Meaghan Lynn Richmond
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K45/06 ; A61K31/506 ; C07D403/04 ; A61K31/416
Abstract:
The present disclosure concerns compounds of Formula (I) or pharmaceutically-acceptable salts thereof, wherein R1, R2 and R3 have any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of cancer.
Public/Granted literature
- US20180237443A1 Chemical Compounds Public/Granted day:2018-08-23
Information query
